H Lundbeck A/S

Common Name

H Lundbeck

Country

Denmark

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

5,000

Ticker

HLUN A

Exchange

Nasdaq Copenhagen

Website

www.lundbeck.com

Description

H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and inter... Show more

Income Statement Balance Sheet

H Lundbeck's Financial Statements Preview

Below are the financial statements of H Lundbeck, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in millions of DKK	2024 as of 2024-12-31	2023 as of 2023-12-31
Intangible assets	40,167^a	20,692^a
Property, plant and equipment	2,721^a	2,499^a
Right-of-use assets	461^a	382^a
Other financial assets	67^a	99^a
Other receivables	284^a	208^a
Deferred tax assets	266^a	238^a
Financial and other assets	617^a	545^a
Non-current assets	43,966^a	24,118^a
Inventories	3,983^a	4,427^a
Trade receivables	3,432^a	2,965^a
Income taxes receivable	39^a	73^a
Other receivables	552^a	588^a
Prepayments	340^a	226^a
Receivables	4,363^a	3,852^a
Cash and cash equivalents	4,664^a	5,010^a
Current assets	13,010^a	13,289^a
Assets	56,976^a	37,407^a
Share capital	996^a	996^a
Foreign currency translation reserve	1,888^a	1,109^a
Hedging reserve	-208^a	63^a
Retained earnings	22,334^a	19,877^a
Equity	25,010^a	22,045^a
Retirement benefit obligations	223^a	216^a
Deferred tax liabilities	5,530^a	2,283^a
Provisions	583^a	388^a
Bank debt and bond debt	16,174^a	3,714^a
Lease liabilities	437^a	351^a
Other payables	439^a	420^a
Non-current liabilities	23,386^a	7,372^a
Retirement benefit obligations	1^a	1^a
Provisions	1,351^a	934^a
Trade payables	4,370^a	4,410^a
Lease liabilities	82^a	86^a
Income taxes payable	316^a	571^a
Other payables	2,460^a	1,988^a
Current liabilities	8,580^a	7,990^a
Liabilities	31,966^a	15,362^a
Equity and liabilities	56,976^a	37,407^a

Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources

pro

Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.

Download granular datasets (CSV/XLS)

Access underlying corporate disclosures (PDF)

Trace all values back to their original sources

Start Your 30-Day Free Trial

Formats Included

Excel

CSV

Json

All data fully traceable to original sources

Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind H Lundbeck’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. H Lundbeck's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

H Lundbeck A/S

H Lundbeck's Financial Statements Preview

Verified Sources Behind H Lundbeck’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Dr Reddy's Laboratories Ltd

Aurobindo Pharma Ltd

Kyowa Kirin Co Ltd

Eisai Co Ltd

Richter Gedeon Vegyeszeti Gyar Nyrt

Galderma Group AG

Account Restricted